期刊文献+

恶性脑胶质瘤的治疗

Therapy for malignant glioma
原文传递
导出
摘要 恶性脑胶质瘤的治疗方法包括手术、放疗、化疗,但总体疗效不佳。近年来替莫唑胺的应用,总体有效率比以往的化疗药物好,但仍有部分耐药;血管生成抑制剂显示出有希望的前景,但价格昂贵;塞来昔布具有抗血管生成活性,可能成为恶性脑胶质瘤新的治疗选择。 Therapies for malignant glioma include surgery, radiotherapy and chemotherapy. In recent years, the overall effective rate of temozolomide is better than other chemotherapy drugs, but partly patients have resistance to temozolomide. Angiogenesis inhibitors show promising activity, but it is expensive. Celecoxib has antiangiogenic activity, which has become a new option.
出处 《国际肿瘤学杂志》 CAS 2012年第4期262-264,共3页 Journal of International Oncology
关键词 神经胶质瘤 血管生成抑制剂 替莫唑胺 塞来昔布 Glioma Angiogenesis inhibitors Temozolomide Celecoxib
  • 相关文献

参考文献13

  • 1Deorah S,Lynch C,Sibenaller ZA. Trends in brain cancer incidence and survival in the United States:Surveillance,Epidemiology,and End Results Program,1973 to 2001[J].Neurosurgical Focus,2006,(04):E1.doi:10.3171/foc.2006.20.4.E1.
  • 2Stupp R,Hegi ME,Mason WP. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase Ⅲ study:5-year analysis of the EORTC-NCIC trial[J].Lancet Oncology,2009,(05):459-466.
  • 3Dunn J,Bahorie A,Alam F. Extent of MGMT promoter methylation correlates with outcome in glioblastomas given temozolomide and radiotherapy[J].British Journal of Cancer,2009,(01):124-131.
  • 4Olson RA,Brastianos PK,Palma DA. Prognostic and predictive value of epigenetic silencing of MGMT in patients with high grade gliomas:a systematic review and meta-analysis[J].Journal of Neuro-Oncology,2011,(02):325-335.
  • 5Chamberlain MC. Temozolomide:therapeutic limitations in the treatment of adult high-grade gliomas[J].Expert Review of Neurotherapeutics,2010,(10):1537-1544.
  • 6Vredenburgh JJ,Desjardins A,Herndon JE 2nd. Phase Ⅱ trial of bevacizumab and irinotecan in recurrent malignant glioma[J].Clinical Cancer Research,2007,(04):1253-1259.
  • 7Moen MD. Bevacizumab:in previously treated glioblastoma[J].Drugs,2010,(02):181-189.
  • 8Wong ET,Gautam S,Malchow C. Bevacizumab for recurrent glioblastoma multiforme:a meta-analysis[J].J Natl Canc Netw,2011,(04):403-407.
  • 9Batchelor T,Duda DG,di Tomaso E. Phase Ⅱ study of cediranib,an oral pan-vascular endothelial growth factor receptor tyrosine kinase inhibitor,in patients with recurrent glioblastoma[J].Journal of Clinical Oncology,2010,(17):2817-2823.
  • 10Chen JC,Chen Y,Su YH. Celecoxib increased expression of 14-3-3sigma and induced apoptosis of glioma cells[J].Anticancer Research,2007,(4B):2547-2554.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部